Skip to main content
. 2019 Feb 1;10(10):1070–1084. doi: 10.18632/oncotarget.26626

B) The initial dose of irinotecan classified by UGT1A1 status.

Wild type, n = 28 (%) Single hetero, n = 26 (%) P value
125 (mg/m2) 4 (15) 4 (15) 1.00
150 (mg/m2) 11 (41) 9 (35) 1.00
165 (mg/m2) 12 (44) 13 (50) 0.812

Abbreviations: Bev, bevacizumab; Ram, ramucirumab; Cmab, cetuximab; Pmab, panitumumab; CPT-11, irinotecan; L-OHP, oxaliplatin.